Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern

Abstract Background Liver metastasis is a poor prognostic factor for treatment of advanced cutaneous melanoma with either immunotherapy or targeted therapies. In this study we focused on NRAS mutated melanoma, a cohort with high unmet clinical need. Methods WT31 melanoma was repeatedly passaged over...

Full description

Bibliographic Details
Main Authors: Bianca Dietsch, Céline Weller, Carsten Sticht, Carolina de la Torre, Martin Kramer, Sergij Goerdt, Cyrill Géraud, Sebastian A. Wohlfeil
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-023-10912-4
_version_ 1797827543884103680
author Bianca Dietsch
Céline Weller
Carsten Sticht
Carolina de la Torre
Martin Kramer
Sergij Goerdt
Cyrill Géraud
Sebastian A. Wohlfeil
author_facet Bianca Dietsch
Céline Weller
Carsten Sticht
Carolina de la Torre
Martin Kramer
Sergij Goerdt
Cyrill Géraud
Sebastian A. Wohlfeil
author_sort Bianca Dietsch
collection DOAJ
description Abstract Background Liver metastasis is a poor prognostic factor for treatment of advanced cutaneous melanoma with either immunotherapy or targeted therapies. In this study we focused on NRAS mutated melanoma, a cohort with high unmet clinical need. Methods WT31 melanoma was repeatedly passaged over the liver after intravenous injections five times generating the subline WT31_P5IV. The colonization of target organs, morphology, vascularization and the gene expression profiles of metastases were analyzed. Results After intravenous injection lung metastasis was significantly decreased and a trend towards increased liver metastasis was detected for WT31_P5IV as compared to parental WT31. Besides, the ratio of lung to liver metastases was significantly smaller. Histology of lung metastases revealed reduced proliferation of WT31_P5IV in relation to WT31 while both size and necrotic areas were unaltered. Liver metastases of both sublines showed no differences in vascularization, proliferation or necrosis. To identify tumor-intrinsic factors that altered the metastatic pattern of WT31_P5IV RNA sequencing was performed and revealed a differential regulation of pathways involved in cell adhesion. Ex vivo fluorescence imaging confirmed that initial tumor cell retention in the lungs was significantly reduced in WT31_P5IV in comparison to WT31. Conclusion This study demonstrates that tumor-intrinsic properties influencing the metastatic pattern of NRAS mutated melanoma are strongly affected by hepatic passaging and the hematogenous route tumor cells take. It has implications for the clinical setting as such effects might also occur during metastatic spread or disease progression in melanoma patients.
first_indexed 2024-04-09T12:50:01Z
format Article
id doaj.art-ef731503ce0e4d28b81d40a5d89c4f70
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-09T12:50:01Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-ef731503ce0e4d28b81d40a5d89c4f702023-05-14T11:19:31ZengBMCBMC Cancer1471-24072023-05-0123111610.1186/s12885-023-10912-4Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic patternBianca Dietsch0Céline Weller1Carsten Sticht2Carolina de la Torre3Martin Kramer4Sergij Goerdt5Cyrill Géraud6Sebastian A. Wohlfeil7Department of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, and Center of Excellence in DermatologyDepartment of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, and Center of Excellence in DermatologyNGS Core Facility, Medical Faculty Mannheim, Heidelberg UniversityNGS Core Facility, Medical Faculty Mannheim, Heidelberg UniversityDepartment of Veterinary Clinical Sciences, Small Animal Clinic, Justus-Liebig-University GiessenDepartment of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, and Center of Excellence in DermatologyDepartment of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, and Center of Excellence in DermatologyDepartment of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, and Center of Excellence in DermatologyAbstract Background Liver metastasis is a poor prognostic factor for treatment of advanced cutaneous melanoma with either immunotherapy or targeted therapies. In this study we focused on NRAS mutated melanoma, a cohort with high unmet clinical need. Methods WT31 melanoma was repeatedly passaged over the liver after intravenous injections five times generating the subline WT31_P5IV. The colonization of target organs, morphology, vascularization and the gene expression profiles of metastases were analyzed. Results After intravenous injection lung metastasis was significantly decreased and a trend towards increased liver metastasis was detected for WT31_P5IV as compared to parental WT31. Besides, the ratio of lung to liver metastases was significantly smaller. Histology of lung metastases revealed reduced proliferation of WT31_P5IV in relation to WT31 while both size and necrotic areas were unaltered. Liver metastases of both sublines showed no differences in vascularization, proliferation or necrosis. To identify tumor-intrinsic factors that altered the metastatic pattern of WT31_P5IV RNA sequencing was performed and revealed a differential regulation of pathways involved in cell adhesion. Ex vivo fluorescence imaging confirmed that initial tumor cell retention in the lungs was significantly reduced in WT31_P5IV in comparison to WT31. Conclusion This study demonstrates that tumor-intrinsic properties influencing the metastatic pattern of NRAS mutated melanoma are strongly affected by hepatic passaging and the hematogenous route tumor cells take. It has implications for the clinical setting as such effects might also occur during metastatic spread or disease progression in melanoma patients.https://doi.org/10.1186/s12885-023-10912-4Cutaneous melanomaMelanoma metastasisLiver metastasisTumor heterogeneity
spellingShingle Bianca Dietsch
Céline Weller
Carsten Sticht
Carolina de la Torre
Martin Kramer
Sergij Goerdt
Cyrill Géraud
Sebastian A. Wohlfeil
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
BMC Cancer
Cutaneous melanoma
Melanoma metastasis
Liver metastasis
Tumor heterogeneity
title Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
title_full Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
title_fullStr Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
title_full_unstemmed Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
title_short Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
title_sort hepatic passaging of nras mutant melanoma influences adhesive properties and metastatic pattern
topic Cutaneous melanoma
Melanoma metastasis
Liver metastasis
Tumor heterogeneity
url https://doi.org/10.1186/s12885-023-10912-4
work_keys_str_mv AT biancadietsch hepaticpassagingofnrasmutantmelanomainfluencesadhesivepropertiesandmetastaticpattern
AT celineweller hepaticpassagingofnrasmutantmelanomainfluencesadhesivepropertiesandmetastaticpattern
AT carstensticht hepaticpassagingofnrasmutantmelanomainfluencesadhesivepropertiesandmetastaticpattern
AT carolinadelatorre hepaticpassagingofnrasmutantmelanomainfluencesadhesivepropertiesandmetastaticpattern
AT martinkramer hepaticpassagingofnrasmutantmelanomainfluencesadhesivepropertiesandmetastaticpattern
AT sergijgoerdt hepaticpassagingofnrasmutantmelanomainfluencesadhesivepropertiesandmetastaticpattern
AT cyrillgeraud hepaticpassagingofnrasmutantmelanomainfluencesadhesivepropertiesandmetastaticpattern
AT sebastianawohlfeil hepaticpassagingofnrasmutantmelanomainfluencesadhesivepropertiesandmetastaticpattern